Global At Home Testing Kits Market Companies

Companies such as Abbott (U.S.), Siemens Healthcare GmbH (Germany), F. Hoffmann-La Roche Ltd (Switzerland), BD (U.S.), Drägerwerk AG & Co. KGaA (Germany), are major players in At-home testing kits market.

In April 2023, Everlywell, a prominent U.S.-based health testing company, expanded its test menu with the launch of new women's health panels, including perimenopause and polycystic ovary syndrome (PCOS) testing kits. These additions reflect the company’s commitment to offering comprehensive, accessible at-home diagnostics for underrepresented health conditions. The expansion underscores the growing consumer demand for personalized, convenient testing solutions and strengthens Everlywell’s position in the evolving at-home healthcare landscape. In March 2023, LetsGetChecked, a global health insights company, announced a collaboration with Walgreens to offer at-home health test kits through retail stores and online platforms. This partnership aims to bridge the gap between traditional retail pharmacies and direct-to-consumer testing, improving accessibility to diagnostic services. The initiative marks a strategic move to broaden consumer reach while enhancing convenience for those seeking health monitoring without clinical visits

The countries covered in the At-home testing kits market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.